🔥🐔 BizChicken 🐔🔥
Companies Similar to CalciMedica, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Anixa Biosciences, Inc.
Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.
Symbol: ANIX
Recent Price: $2.50
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Sector: Healthcare
Employees: 4
Address: 3150 Almaden Expressway, San Jose, CA 95118
Phone: 408 708 9808
Last updated: 2024-12-31
Capricor Therapeutics, Inc.
CAP-1002
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing transformative cell and exosome-based therapeutics aimed at treating and preventing a range of diseases and disorders. Their lead candidate, CAP-1002, is designed for Duchenne muscular dystrophy and cytokine storm interventions.
About | Leadership | Directors | About | About | Contact | Careers | About | About | About | About
Symbol: CAPR
Recent Price: $13.76
Industry: Biotechnology
CEO: Dr. Linda Marbán Ph.D.
Sector: Healthcare
Employees: 101
Address: 10865 Road to the Cure, San Diego, CA 92121
Phone: 310 358 3200
Leadership
- Linda Marbán, Ph.D., Chief Executive Officer and Director
- Kristi A. H. Elliott, Ph.D., Chief Science Officer
- AJ Bergmann, M.B.A., Chief Financial Officer
- Karen G. Krasney, J.D., Executive Vice President and General Counsel
- Mark Awadalla, Vice President of Clinical Operations
- Jonathan Tayco, Vice President of Program Management and Business Operations
- Minghao Sun, Ph.D., Vice President of Research and Product Development
- Yushi Feng, Ph.D., Vice President of Regulatory Affairs
- Frank Litvack M.D., FACC, Executive Chairman
- Paul G. Auwaerter, M.D., M.B.A., FIDSA, Director
- Earl M. (Duke) Collier Jr., Director
- George W. Dunbar, Jr., Director
- Philip J. Gotwals, Ph.D., Director
- Michael Kelliher, Director
- David B. Musket, Director
- Karimah Es Sabar, Director
Last updated: 2024-12-31
Lyra Therapeutics, Inc.
XTreo technology platform
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.
Symbol: LYRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Dr. Maria Palasis Ph.D.
Sector: Healthcare
Employees: 88
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617 393 4600
Leadership
- Harlan W. Waksal, M.D., Executive Chairman
- Maria Palasis, Ph.D., President and Chief Executive Officer
- Jason Cavalier, Chief Financial Officer
- Robert Kern, M.D., Chief Clinical Advisor
- Ronan O’Brien, Chief Legal Officer
- Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
- Gloria Cosgrove, Senior Vice President of Quality
- Allison Nance, Senior Vice President of Regulatory Affairs
- Michael Altman, CFA, Managing Director, Perceptive Advisors
- Ann Merrifield, Life Sciences Advisor and Board Director
- Konstantin Poukalov, Managing Director, Perceptive Advisors
- Bradford Smith, Board Director
- Nancy L. Snyderman, M.D., Board Director
- Jim Tobin, Lead Independent Director
- Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
- George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
180 Life Sciences Corp.
Therapeutics for chronic pain, inflammation, fibrosis, and inflammatory diseases
1180 Life Sciences Corp. is a clinical-stage biotechnology company focused on developing therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis, using platforms such as fibrosis and anti-TNF, synthetic CBD analogs, and a7n ACh R.
Symbol: ATNF
Recent Price: $2.98
Industry: Biotechnology
CEO: Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Sector: Healthcare
Employees: 4
Address: Building 4, Palo Alto, CA 94306
Phone: 650 507 0669
Last updated: 2024-11-08
Aura Biosciences, Inc.
AU-011
Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.
About | About | Management | Directors | About | Contact | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: AURA
Recent Price: $8.13
Industry: Biotechnology
CEO: Dr. Elisabet de los Pinos Ph.D.
Sector: Healthcare
Employees: 88
Address: 85 Bolton Street, Cambridge, MA 02140
Phone: 617 500 8864
Leadership
- David Johnson, Chairman
- Elisabet de los Pinos, PhD, Chief Executive Officer
- Giovanni Mariggi, PhD, Director
- Antony Mattessich, Director
- Sapna Srivastava, PhD, Director
- Karan Takhar, Director
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
Biora Therapeutics, Inc.
oral biotherapeutics
Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.
About | Leadership | About | Contact | Contact | Careers | Careers | About | Careers | Careers | About | About
Symbol: BIOR
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Sector: Healthcare
Employees: 58
Address: 4330 La Jolla Village Drive, San Diego, CA 92122
Phone: 855 293 2639
Leadership
- Adi Mohanty, MBA, Chief Executive Officer & Board Member
- Eric d’Esparbes, Chief Financial Officer
- Robyn Hatton, Head of Human Resources
- Ariella Kelman, MD, Chief Medical Officer
- James Knight, MBA, Head of Business Development
- Clarke Neumann, JD, General Counsel and Secretary
- Paul Shabram, MBA, Head of Technical Operations
- Sharat Singh, PhD, Head of Research
- Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
- Jeffrey Alter, MBA, Board Chair
- Jeffrey Ferrell, Board Member
- Jill Howe, Board Member
- Brian Kotzin, MD, Board Member
- Lynne Powell, MBA, Board Member
- Bruce Sands, MD, MS, Advisory Board Chair
- Geert D’Haens, MD, PhD, Advisory Board Member
- Brian Feagan, MD, FRCPC, Advisory Board Member
- Séverine Vermeire, MD, PhD, Advisory Board Member
- Satish Rao, MD, PhD, Advisory Board Chair
- William Chey, MD, Advisory Board Member
- Anthony Lembo, MD, Advisory Board Member
- Mark Pimentel, MD, Advisory Board Member
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
CalciMedica, Inc.
Auxora
Calci Medica, Inc. is a clinical-stage biotechnology company focusing on therapies for life-threatening inflammatory diseases, with a proprietary CRAC channel inhibitor technology. Its lead product candidate, Auxora, aims to treat conditions such as acute pancreatitis and acute kidney injury.
Symbol: CALC
Recent Price: $3.29
Industry: Biotechnology
CEO: Dr. A. Rachel Leheny Ph.D.
Sector: Healthcare
Employees: 13
Address: 505 Coast Boulevard South, La Jolla, CA 92037
Phone: 858-952-5500
Last updated: 2024-12-31
Cue Biopharma, Inc.
CUE-101
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.
About | Leadership | About | Directors | About | Contact | About | About | About | Careers | Careers | Careers | Careers | Careers | About
Symbol: CUE
Recent Price: $1.02
Industry: Biotechnology
CEO: Mr. Daniel R. Passeri J.D., M.Sc.
Sector: Healthcare
Employees: 53
Address: 21 Erie Street, Cambridge, MA 02139
Phone: 617 949 2680
Leadership
- Dan Passeri, Chief Executive Officer
- Anish Suri, President and Chief Scientific Officer
- Lucinda Warren, Chief Business Officer
- Matteo Levisetti, Chief Medical Officer
- Kerri-Ann Millar, Chief Financial Officer
- Colin Sandercock, Senior Vice President and General Counsel
- Frank Morich, M.D., Ph.D., Chairman of the Board
- Dan Passeri, M.Sc., J.D., Chief Executive Officer
- Peter Kiener, D.Phil.,
- Fred Driscoll,
- Patrick Verheyen,
- Pamela D. Garzone, Ph.D.,
Last updated: 2024-12-31
Janux Therapeutics, Inc.
Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr)
Janux Therapeutics is a biopharmaceutical company developing cancer therapeutics leveraging their proprietary TRACTr and TRACIr platform technologies, targeting specific antigens and improving T cell anti-tumor activity.
Symbol: JANX
Recent Price: $52.50
Industry: Biotechnology
CEO: Dr. David Alan Campbell Ph.D.
Sector: Healthcare
Employees: 64
Address: 11099 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858 750 4700
Last updated: 2024-12-31
Lisata Therapeutics, Inc.
HONEDRA, XOWNA, CLBS201
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cellular therapies to reverse disease and regenerate damaged tissue.
About | Leadership | Directors | Contact | Contact | Careers | Careers | About | About | About | Careers | Contact | Careers | Careers | Careers
Symbol: LSTA
Recent Price: $2.94
Industry: Biotechnology
CEO: Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Sector: Healthcare
Employees: 25
Address: 110 Allen Road, Basking Ridge, NJ 07920
Phone: 908 842 0100
Leadership
- David J. Mazzo, PhD, President and Chief Executive Officer
- Kristen K. Buck, MD, Executive Vice President of R&D and Chief Medical Officer
- Gregory S. Berkin, Chief Information Officer and Data Protection Officer
- Gail Holler, Vice President, Human Resources
- John D. Menditto, Vice President, Investor Relations and Corporate Communications
- James Nisco, Senior Vice President, Finance and Treasury and Chief Accounting Officer
- William K. Sietsema, PhD, Vice President, Global Regulatory Affairs
- Ryan Quick, Vice President, Chemistry, Manufacturing and Controls
- Tariq Imam, Vice President, Business Development and Operations and Corporate Counsel
- Gregory B. Brown, MD, Chairman
- Steven M. Klosk, Director
- Cynthia L. Flowers, Director
- Mohammad Azab, MD, MSc, MBA, Director
- Heidi Henson, Director
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Zura Bio Limited
ZB-168
Zura Bio Limited is a clinical-stage biotechnology company based in San Diego, California, focusing on developing novel medicines for immune and inflammatory disorders.
Symbol: ZURA
Recent Price: $2.55
Industry: Biotechnology
CEO: Mr. Robert Lisicki
Sector: Healthcare
Employees: 14
Address: 4225 Executive Square, San Diego, CA 92037
Phone: 858 247 0520
Last updated: 2024-12-31
Cencora
pharmaceutical products
Cencora, Inc. sources and distributes pharmaceutical products, offering a range of services including pharmacy management, supply management software, packaging solutions, and clinical trial support to various healthcare providers and manufacturers.
About | About | About | History | Leadership | Contact | Careers | Careers | Culture | Careers | DEI | Careers | Careers | Careers | DEI | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: COR
Recent Price: $224.71
Industry: Medical - Distribution
CEO: Dr. Robert P. Mauch Ph.D., PharmD
Sector: Healthcare
Employees: 46000
Address: 1 West First Avenue, Conshohocken, PA 19428
Phone: 610 727 7000
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31